Cargando…
RNA-Seq Analysis Reveals CCR5 as a Key Target for CRISPR Gene Editing to Regulate In Vivo NK Cell Trafficking
SIMPLE SUMMARY: Adoptive immunotherapy utilizing ex vivo expanded natural killer (NK) cells is being explored in the clinical and preclinical settings to treat hematological tumors. Previous work has shown that a large fraction of ex vivo expanded NK cells traffic into the liver following i.v. infus...
Autores principales: | Levy, Emily R., Clara, Joseph A., Reger, Robert N., Allan, David S. J., Childs, Richard W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7922167/ https://www.ncbi.nlm.nih.gov/pubmed/33669611 http://dx.doi.org/10.3390/cancers13040872 |
Ejemplares similares
-
High-affinity CD16 integration into a CRISPR/Cas9-edited CD38 locus augments CD38-directed antitumor activity of primary human natural killer cells
por: Clara, Joseph Andrew, et al.
Publicado: (2022) -
Efficient mRNA-Based Genetic Engineering of Human NK Cells with High-Affinity CD16 and CCR7 Augments Rituximab-Induced ADCC against Lymphoma and Targets NK Cell Migration toward the Lymph Node-Associated Chemokine CCL19
por: Carlsten, Mattias, et al.
Publicado: (2016) -
CCR5 Is Essential for NK Cell Trafficking and Host Survival following Toxoplasma gondii Infection
por: Khan, Imtiaz A, et al.
Publicado: (2006) -
Bortezomib sensitizes multiple myeloma to NK cells via ER-stress-induced suppression of HLA-E and upregulation of DR5
por: Carlsten, Mattias, et al.
Publicado: (2018) -
CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy
por: Elmas, Ezgi, et al.
Publicado: (2022)